The relative efficacy of neoadjuvant endocrine therapy vs chemotherapy in postmenopausal women with ER-positive breast cancer

被引：0
|
作者：
Semiglazov, VF [1 ]
Semiglazov, V [1 ]
Ivanov, V [1 ]
Bozhok, A [1 ]
Ziltsova, E [1 ]
Paltuev, R [1 ]
Dashian, G [1 ]
Kletzel, A [1 ]
Topuzov, E [1 ]
Berstein, L [1 ]
机构：
[1] NN Petrov Oncol Res Inst, St Petersburg, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
519
引用
收藏
页码：7S / 7S
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients
    Semiglazov, VF
    Ivanov, VG
    Semiglazov, VV
    Ziltsova, EK
    Keltzel, AA
    Melnikova, OA
    Topuzov, EE
    Paltuev, RM
    Bozhok, AA
    Dashian, GA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S107
  • [2] Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer
    不详
    [J]. BREAST, 2005, 14 : S39 - S39
  • [3] Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 117 - 117
  • [4] The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Zhiltzova, E. R.
    Kletsel, A. E.
    Dashyan, G. A.
    Bozhok, A. A.
    Paltuev, R. M.
    Berstein, L. M.
    Krivorotko, R. V.
    [J]. BREAST, 2007, 16 : S50 - S50
  • [5] Phase II study of preoperative endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    Semigiazov, Vladimir F.
    Ivanov, Vadim G.
    Bozhok, Alla A.
    Semiglazov, Vjacheslav V.
    Melnikova, Olga A.
    Kletzel, Alexander A.
    Topuzov, Eldar E.
    Paltuev, Ruslan M.
    Dashian, Garik A.
    Berstein, Lev M.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 55 - 55
  • [6] Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Ziltsova, E. K.
    Dashian, G. A.
    Kletzel, A.
    Bozhok, A. A.
    Topuzov, E. E.
    Paltuev, R. M.
    Berstein, L. M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 71 - 71
  • [7] Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database
    LeVasseur, Nathalie
    Willemsma, Kaylie-Anne
    Li, Huaqi
    Gondara, Lovedeep
    Yip, Walter C.
    Illmann, Caroline
    Chia, Stephen K.
    Simmons, Christine
    [J]. CLINICAL BREAST CANCER, 2019, 19 (06) : E683 - E689
  • [8] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Li-Tong Yao
    Mo-Zhi Wang
    Meng-Shen Wang
    Xue-Ting Yu
    Jing-Yi Guo
    Tie Sun
    Xin-Yan Li
    Ying-Ying Xu
    [J]. World Journal of Clinical Cases, 2019, (15) : 1937 - 1953
  • [9] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Yao, Li-Tong
    Wang, Mo-Zhi
    Wang, Meng-Shen
    Yu, Xue-Ting
    Guo, Jing-Yi
    Sun, Tie
    Li, Xin-Yan
    Xu, Ying-Ying
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (15) : 1937 - 1953
  • [10] Neoadjuvant chemotherapy versus neoadjuvant hormonal therapy in postmenopausal women with ER-positive, HER2/neu negative locally advanced breast cancer
    Ambros, Tadeu Frantz
    Reis, Isildinha M.
    Bagga, Dilprit
    Villasboas, Jose Caetano
    Blieden, Clifford
    Sujoy, Victoria
    Wright, Jean L.
    Saigal, Kunal
    Fernandez, Carmen Gomez
    Hurley, Judith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345